Progress, Potential and Possibilities Pharmaceutical Industry Thought Leaders 24/7 Stream

Progress, Potential and Possibilities ( 24/7 Stream of Recent And Past Episodes with Pharmaceutical Industry thought leaders.

In this stream please find episodes with –

– Dr. P. Ryan Potts, PhD, VP and Head, Induced Proximity Platform, Amgen – Leading The Next Wave Of Innovation In Drug Discovery, To Modulate “Undruggable” Targets –

– Prof. Nadeem Sarwar – Corporate VP, Co-Founder & Head, Transformational Prevention Unit, Novo Nordisk – Increasing Obesity-Free Life Years So People Live Healthier And Longer Lives –

– Dr. Uwe Schoenbeck, Ph.D. – CSO / SVP, Pfizer – Leading collaborative innovation for unmet medical needs –

– Mr. Joel Greshock – VP, Oncology, Data Science & Digital Health – Janssen Research & Development – Johnson & Johnson Group Of Companies –

– Ms. Ashley Gaines – VP, Head of Breast Cancer Franchise, US Oncology Business Unit, AstraZeneca – Transforming The Diagnosis And Treatment Of Breast Cancer –

– Dr. Stephen Moran, PhD, Global Program Head, Neuroendocrine Tumors & Other Radiosensitive Cancers, Novartis – Advanced Accelerator Applications –

– Dr. Andrew Adams, PhD – Vice President of Neurodegeneration Research at Eli Lilly and Co-Director, Lilly Institute for Genetic Medicine – discussing targeting root causes of diseases –

– Dr. Emre Ozcan, PhD, VP, Global Head of Digital Health & Walid Mehanna, Group Data Officer And Senior Vice President, Merck KGaA, Darmstadt, Germany – Digital Technology As A Force For Good In People’s Lives –

– Dr. Elizabeth Garner, MD, MPH – Chief Scientific Officer, U.S., Ferring Pharmaceuticals; President, American Medical Women’s Association, discussing the future of women’s / maternal health, fertility and fem-tech –

– Dr. Devi SenGupta, MD, MPhil – Executive Director of Clinical Development, Gilead Sciences – leading the company’s HIV cure development program –

– Dr. Xiaorong He, Ph.D., MBA – SVP, Head of Global Development Sciences and U.S. Site Head of Non-Clinical Development, Boehringer Ingelheim – Transformative Innovation, Scientific Excellence & Patient Centricity –

– William Taranto – President, Global Health Innovation Fund, Merck – Corporate Venturing For Integrated Healthcare Solutions

#Pharmaceutical #Biopharmaceutical #Biotechnology #Amgen #EliLilly #NovoNordisk #AstraZeneca #Pfizer #Novartis #Merck #JohnsonAndJohnson #GileadSciences #BoehringerIngelheim #Ferring #Obesity #Oncology #HIV #AIDS #Neurodegeneration #WomensHealth #DigitalHealth #STEM #Innovation #Science #Technology #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting

source